Cannabis Therapy (OTCQB:CTCO +1.2%) licenses Canna-Pet's animal health products and technology. Under the terms of the agreement, CTCO will pay Canna-Pet royalties on product sales in exchange for an exclusive worldwide license and rights to the technology and hemp-based products currently developed by Canna-Pet.
Cannabis Therapy licenses animal health products
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs